BACKGROUND: Insulin decreases the incidence of sepsis and improves mortality of critically ill patients. In endotoxemic as well as in thermally injured rats, insulin attenuates the systemic inflammatory response by decreasing the proinflammatory and increasing the antiinflammatory cascade. The aim of the present study was to determine the effects of insulin on cell survival, cell activity, apoptosis, and proinflammatory response in a human macrophage-like cell line (THP-1 cells) stressed with lipopolysaccharide (LPS). MATERIALS AND METHODS: Human macrophages were stressed with LPS and received either saline or insulin. Cell viability was analyzed by MTS, apoptosis was detected using JC-1 and terminal deoxynucleotidyl transferase-mediated nick end labeling-staining, and to elucidate on the signaling pathway, we used wortmannin as a phosphatidylinositol-3-kinase inhibitor. Tumor necrosis factor (TNF) and interleukin-1beta (IL-1beta) were measured to determine the effect of insulin on proinflammatory cytokine expression. RESULTS: Insulin caused a significant increase in cell viability and significantly reduced apoptosis in LPS-stimulated human macrophages in a dose-dependent manner. The antiapoptotic effect of insulin could be completely blocked with the addition of wortmannin. Insulin significantly decreased TNF and IL-1beta in endotoxemic human macrophages. CONCLUSIONS: Our results indicate that insulin exerts antiapoptotic effects and reduces the expression of proinflammatory cytokines in endotoxemic human macrophages. The antiapoptotic effects are mediated via the phospatidylinositol-3-kinase-pathway.
BACKGROUND:Insulin decreases the incidence of sepsis and improves mortality of critically illpatients. In endotoxemic as well as in thermally injured rats, insulin attenuates the systemic inflammatory response by decreasing the proinflammatory and increasing the antiinflammatory cascade. The aim of the present study was to determine the effects of insulin on cell survival, cell activity, apoptosis, and proinflammatory response in a human macrophage-like cell line (THP-1 cells) stressed with lipopolysaccharide (LPS). MATERIALS AND METHODS:Human macrophages were stressed with LPS and received either saline or insulin. Cell viability was analyzed by MTS, apoptosis was detected using JC-1 and terminal deoxynucleotidyl transferase-mediated nick end labeling-staining, and to elucidate on the signaling pathway, we used wortmannin as a phosphatidylinositol-3-kinase inhibitor. Tumor necrosis factor (TNF) and interleukin-1beta (IL-1beta) were measured to determine the effect of insulin on proinflammatory cytokine expression. RESULTS:Insulin caused a significant increase in cell viability and significantly reduced apoptosis in LPS-stimulated human macrophages in a dose-dependent manner. The antiapoptotic effect of insulin could be completely blocked with the addition of wortmannin. Insulin significantly decreased TNF and IL-1beta in endotoxemic human macrophages. CONCLUSIONS: Our results indicate that insulin exerts antiapoptotic effects and reduces the expression of proinflammatory cytokines in endotoxemic human macrophages. The antiapoptotic effects are mediated via the phospatidylinositol-3-kinase-pathway.
Authors: Nazzy Pakpour; Vanessa Corby-Harris; Gabriel P Green; Hannah M Smithers; Kong W Cheung; Michael A Riehle; Shirley Luckhart Journal: Infect Immun Date: 2012-04-02 Impact factor: 3.441
Authors: Robert Kraft; David N Herndon; Ahmed M Al-Mousawi; Felicia N Williams; Celeste C Finnerty; Marc G Jeschke Journal: Lancet Date: 2012-01-31 Impact factor: 79.321
Authors: Yosef Levenbrown; Scott Penfil; Elena Rodriguez; Yan Zhu; Jobayer Hossain; A Majeed Bhat; Anne Hesek; Karen B O'Neil; Kelly Tobin; Thomas H Shaffer Journal: Inflammation Date: 2013-12 Impact factor: 4.092
Authors: Matthew E Woodske; Takuya Yokoe; Baobo Zou; Lia C Romano; Taylor C Rosa; Adolfo Garcia-Ocana; Laura C Alonso; Christopher P O'Donnell; Bryan J McVerry Journal: Crit Care Med Date: 2009-09 Impact factor: 7.598
Authors: Yaeko Hiyama; Alexandra H Marshall; Robert Kraft; Nour Qa'aty; Anna Arno; David N Herndon; Marc G Jeschke Journal: Mol Med Date: 2013-03-05 Impact factor: 6.354
Authors: Linda B Kidd; Gernot A Schabbauer; James P Luyendyk; Todd D Holscher; Rachel E Tilley; Michael Tencati; Nigel Mackman Journal: J Pharmacol Exp Ther Date: 2008-04-29 Impact factor: 4.030